Nsys Co., Ltd. (KOSDAQ:333620)

Elevation Oncology Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	79,661	79,041	103,735	104,130	214,821	-
Market Cap Growth	-16.31%	-23.80%	-0.38%	-51.53%	-	-
Enterprise Value	69,817	61,482	99,436	96,745	188,005	-
Last Close Price	7710.00	7650.00	9827.23	9710.24	19728.45	-
PE Ratio	9.30	7.78	46.12	29.46	44.49	-
Forward PE	-	15.11	15.11	15.11	19.31	-
PS Ratio	1.28	1.26	2.03	2.48	5.03	-
PB Ratio	1.25	1.24	1.80	1.87	3.93	-
P/TBV Ratio	1.30	1.29	1.81	1.88	3.96	-
P/FCF Ratio	24.35	6.74	-	113.11	-	-
P/OCF Ratio	19.06	6.48	-	11.65	137.36	-
EV/Sales Ratio	1.12	0.98	1.94	2.31	4.40	-
EV/EBITDA Ratio	6.80	5.31	36.70	21.16	23.36	-
EV/EBIT Ratio	7.73	5.88	53.63	23.84	24.42	-
EV/FCF Ratio	21.34	5.24	-	105.09	-	-
Debt / Equity Ratio	0.14	0.13	0.26	0.19	0.11	0.42
Debt / EBITDA Ratio	0.82	0.73	5.47	2.37	0.71	0.81
Debt / FCF Ratio	2.68	0.72	-	11.75	-	2.01
Asset Turnover	0.64	0.65	0.57	0.55	0.87	1.48
Inventory Turnover	4.19	4.42	3.40	3.63	6.62	10.95
Quick Ratio	1.22	1.32	0.93	1.58	3.12	1.28
Current Ratio	1.79	1.83	1.50	2.69	3.99	1.73
Return on Equity (ROE)	13.69%	16.43%	3.96%	6.40%	13.87%	36.60%
Return on Assets (ROA)	6.17%	6.71%	1.29%	3.31%	9.86%	18.87%
Return on Capital (ROIC)	8.30%	9.02%	1.67%	3.99%	11.79%	25.40%
Return on Capital Employed (ROCE)	14.60%	16.10%	3.20%	6.00%	13.70%	48.60%
Earnings Yield	10.94%	12.85%	2.17%	3.39%	2.25%	-
FCF Yield	4.11%	14.84%	-0.69%	0.88%	-3.35%	-
Dividend Yield	2.06%	2.09%	-	-	-	-
Payout Ratio	4.74%	4.07%	27.56%	20.91%	-	-
Buyback Yield / Dilution	-7.93%	-7.93%	1.62%	-3.13%	-27.12%	-4.24%
Total Shareholder Return	-5.86%	-5.84%	1.62%	-3.13%	-27.12%	-4.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.